Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of FWD1802-based treatment strategies in ER-positive/HER2-negative advanced or metastatic breast cancer
CTR20251995Phase 2Active
- Sponsor
- Forward Pharma
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fwd1802 in breast cancer, sponsored by Forward Pharma. Started Jun 2025; status: active.
02
Drugs
fwd1802
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20251995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251995.